Article Abstract

Approach and management of checkpoint inhibitor-related immune hepatitis

Authors: Aravind Sanjeevaiah, Thomas Kerr, Muhammad Shaalan Beg


Immune checkpoint inhibitors have promising clinical activity across multiple gastrointestinal cancers and immune-mediated hepatotoxicity is particularly relevant for this group of patients. In this article we will review the recognition, workup and management of suspected checkpoint inhibitor related immune-hepatitis.